Micro-X Secures 3-Year Supply Agreement Covering 700+ US Healthcare Facilities
Micro-X has secured its first supply agreement with a leading US healthcare provider for its Rover Plus mobile radiology system, opening access to over 700 facilities nationwide.
- First major US healthcare supply agreement for Micro-X’s Rover Plus
- Agreement covers a network of 700+ hospitals and outpatient centers
- Result of competitive tender and successful in-hospital evaluation
- Three-year initial term with tiered pricing and standard commercial terms
- Rover Plus added to approved procurement list, enabling streamlined purchases
A Milestone for Micro-X in the US Market
Australian medical imaging innovator Micro-X Ltd has taken a significant step in its US expansion by signing a supply agreement with a major, though undisclosed, US healthcare provider. This deal marks the company’s first formal entry into the US hospital procurement ecosystem for its Rover Plus mobile radiology system, a product that leverages Micro-X’s proprietary cold cathode x-ray technology.
The customer operates an extensive network of over 700 healthcare facilities, including acute hospitals, surgical centers, and outpatient services. Following a rigorous competitive tender and a successful in-hospital evaluation across four hospitals, the Rover Plus has been approved for procurement across this network without the need for further evaluation or tender processes. This streamlined access is a rare and valuable endorsement in a typically conservative healthcare market.
Strategic Implications and Commercial Outlook
The agreement, spanning an initial three-year term, includes tiered pricing, supply lead times, warranties, and compliance obligations. Micro-X is well-prepared to meet anticipated demand, holding $4 million worth of Rover Plus inventory and ramping up its supply chain accordingly. The deal not only validates the technical merits of the Rover Plus but also signals growing trust in Micro-X’s ability to deliver reliable, versatile mobile radiology solutions.
CEO Kingsley Hall highlighted the significance of this breakthrough, noting the challenge of entering a market dominated by established brands. The agreement is a key step toward Micro-X’s broader ambition to become a recognized medical imaging vendor in the US, with future plans to expand into CT imaging technologies.
Looking Ahead – Growth and Challenges
While the identity of the healthcare provider remains confidential, the scale of the network involved suggests substantial revenue potential. Micro-X’s sales and technical teams are now focused on supporting the customer’s needs for new and replacement mobile radiology units, with ongoing negotiations for a second sales opportunity with another major procurement group.
Despite this positive momentum, the company is careful to clarify that the agreement does not constitute a product endorsement or exclusive arrangement. The healthcare sector’s cautious approach means that widespread adoption will require continued demonstration of value and reliability.
Bottom Line?
Micro-X’s US foothold with Rover Plus sets the stage for broader market penetration but demands sustained execution and trust-building.
Questions in the middle?
- Who exactly is the major US healthcare provider behind the agreement?
- What are the expected order volumes and revenue timelines from this deal?
- How will Micro-X compete against entrenched medical imaging brands in the US?
